Filter and sort all 500 stocks
Today's biggest gainers and losers
Visual sector performance
Nuvectis gains two experimental drugs in licensing deal with China's Haisco
Nuvectis Pharma CEO Says Increased Dose Intensity Needed To Drive More Efficacy From Ovarian Cancer Lead Drug